A previous study in cancer cell lines reported that αvβ3 integrin signaling might activate the ERK pathway, resulting in ETV4 transcription, PD-L1/L2 expression, and evasion attacks from the immune system (Ma et al., 2021). Here, CD274 is linked to cancer.